Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 18.37 -0.57 (-3.01%) Market Cap: 1.25 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 12:45PM GMT
Release Date Price: $9.94 (-4.61%)
Joey Stringer
Needham & Company - Analyst

Good morning, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, that's Phathom Pharmaceuticals. Joining us today from the company is President and CEO, Terrie Curran; CFO, Molly Henderson; Chief Operating Officer, Azmi Nabulsi; Chief Commercial Officer, Martin Gilligan; and also, Chief Development Officer, Tom Harris. I think I got everyone.

(Conference Instructions) So, with that, that was with the Phanthom team. Thanks so much for joining us today.

Terrie Curran
Phathom Pharmaceuticals, Inc. - President & CEO

Thanks, Joey, and thanks for the invitation to be here. It's a real pleasure.

Joey Stringer
Needham & Company - Analyst

Of course.

Terrie Curran
Phathom Pharmaceuticals, Inc. - President & CEO

So, I'll pick it up, and I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot